{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:56:11Z","timestamp":1790798171760,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Cardiac sarcoidosis (CS) is an inflammatory granulomatous cardiomyopathy associated with atrioventricular block, ventricular arrhythmias, heart failure (HF), and sudden cardiac death (SCD). Diagnosis and management remain challenging because myocardial involvement is patchy and evidence from randomized trials is limited. This review summarizes current knowledge on CS, focusing on advances in diagnosis, immunosuppression, and prevention of arrhythmic events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Cardiac involvement is clinically recognized in 5\u201310% of patients with sarcoidosis but is more frequent in imaging and autopsy studies. Cardiac magnetic resonance (CMR) and ^18F-fluorodeoxyglucose positron emission tomography (FDG-PET) provide complementary information on myocardial scar and active inflammation. Multimodality imaging, extracardiac tissue diagnosis, guided endomyocardial biopsy, and consensus criteria improve diagnostic confidence. Corticosteroids remain first-line therapy for active inflammation, while steroid-sparing agents are increasingly used to reduce corticosteroid exposure or treat persistent disease. Inflammasome\/interleukin-1 inhibition is an emerging targeted strategy, but its clinical efficacy remains unproven. SCD risk stratification now extends beyond left ventricular ejection fraction to include ventricular arrhythmias, conduction disease, ventricular dysfunction, and myocardial scar burden. Implantable cardioverter-defibrillator therapy remains central in selected high-risk patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>CS requires early recognition of both inflammation and myocardial scar. CMR and FDG-PET are central to diagnosis, prognosis, and therapeutic decisions, while management combines immunosuppression, HF therapy, and arrhythmia prevention. Major uncertainties remain regarding optimal diagnostic criteria, immunosuppression strategies, serial imaging, and primary-prevention ICD selection. Prospective studies and randomized trials are needed to refine treatment and risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-026-02417-w","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:15:51Z","timestamp":1790748951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Sarcoidosis: A Practical Guide for Cardiologists"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0245","authenticated-orcid":false,"given":"Massimo","family":"Imazio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Collini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2417_CR1","doi-asserted-by":"publisher","unstructured":"Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, Drent M, Judson MA, Wolff G. Sarcoidosis in America. Analysis Based on Health Care Use. Ann Am Thorac Soc. 2016;13:1244-52. https:\/\/doi.org\/10.1513\/AnnalsATS.201511-760OC.\u00a0PMID: 27509154.","DOI":"10.1513\/AnnalsATS.201511-760OC"},{"key":"2417_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","volume":"26","author":"EV Arkema","year":"2020","unstructured":"Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26:527\u201334. https:\/\/doi.org\/10.1097\/MCP.0000000000000715. PMID: 32701677; PMCID: PMC7755458.","journal-title":"Curr Opin Pulm Med"},{"key":"2417_CR3","doi-asserted-by":"publisher","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","volume":"149","author":"RK Cheng","year":"2024","unstructured":"Cheng RK, Kittleson MM, Beavers CJ, Birnie DH, Blankstein R, Bravo PE, Gilotra NA, Judson MA, Patton KK, Rose-Bovino L, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association. Circulation. 2024;149:e1197\u2013216. https:\/\/doi.org\/10.1161\/CIR.0000000000001240. Epub 2024 Apr 18.","journal-title":"Circulation"},{"key":"2417_CR4","doi-asserted-by":"publisher","unstructured":"Sharma R, Kouranos V, Cooper LT, Metra M, Ristic A, Heidecker B, Baksi J, Wicks E, Merino JL, Klingel K, Imazio M, de Chillou C, Tsch\u00f6pe C, Kuchynka P, Petersen SE, McDonagh T, L\u00fcscher T, Filippatos G. Management of cardiac sarcoidosis. Eur Heart J. 2024;45(30):2697\u20132726. https:\/\/doi.org\/10.1093\/eurheartj\/ehae356.\u00a0PMID: 38923509.","DOI":"10.1093\/eurheartj\/ehae356"},{"key":"2417_CR5","doi-asserted-by":"publisher","unstructured":"Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. (1993). Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 43(7\u20138):372-6. https:\/\/doi.org\/10.1111\/j.1440-1827.1993.tb01148.x.\u00a0PMID: 8372682.","DOI":"10.1111\/j.1440-1827.1993.tb01148.x"},{"key":"2417_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","volume":"151","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Lower EE, Li HP, Costea A, Attari M, Baughman RP. Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival. Chest. 2017;151:139\u201348. https:\/\/doi.org\/10.1016\/j.chest.2016.08.1457. Epub 2016 Sep 8. PMID: 27614001.","journal-title":"Chest"},{"key":"2417_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","volume":"11","author":"MR Dweck","year":"2018","unstructured":"Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2018;11:94\u2013107. Epub 2017 Jun 14. PMID: 28624396; PMCID: PMC5995315.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2417_CR8","doi-asserted-by":"publisher","unstructured":"Rossides M, Grunewald J, Eklund A, Kullberg S, Di Giuseppe D, Askling J, Arkema EV. Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study. Eur Respir J. 2018;52(2):1800385. https:\/\/doi.org\/10.1183\/13993003.00385-2018.\u00a0PMID: 29946010.","DOI":"10.1183\/13993003.00385-2018"},{"issue":"9","key":"2417_CR9","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/modpathol.2012.80","volume":"25","author":"M Negi","year":"2012","unstructured":"Negi M, Takemura T, Guzman J, Uchida K, Furukawa A, Suzuki Y, Iida T, Ishige I, Minami J, Yamada T, Kawachi H, Costabel U, Eishi Y. Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol. 2012;25(9):1284\u201397. https:\/\/doi.org\/10.1038\/modpathol.2012.80. Epub 2012 May 18. PMID: 22596102; PMCID: PMC3434354.","journal-title":"Mod Pathol"},{"key":"2417_CR10","doi-asserted-by":"publisher","unstructured":"Chen ES, Moller DR. Sarcoidosis\u2013scientific progress and clinical challenges. Nat Rev Rheumatol. 2011;7(8):457\u2009\u2013\u200967. https:\/\/doi.org\/10.1038\/nrrheum.2011.93. PMID: 21750528.","DOI":"10.1038\/nrrheum.2011.93"},{"key":"2417_CR11","doi-asserted-by":"publisher","first-page":"e017693","DOI":"10.1161\/CIRCIMAGING.125.017693","volume":"20","author":"S Divakaran","year":"2025","unstructured":"Divakaran S. How to Use Imaging: Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2025;20:e017693. https:\/\/doi.org\/10.1161\/CIRCIMAGING.125.017693. Epub ahead of print. PMID: 40391428.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"2417_CR12","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","volume":"25","author":"DR Okada","year":"2018","unstructured":"Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti VR, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018;25(4):1136\u201346. https:\/\/doi.org\/10.1007\/s12350-016-0658-1. Epub 2016 Sep 9.","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"2417_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietil\u00e4-Effati P, Utrianen S, Kupari M. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624\u201332. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011522. Epub 2014 Dec 19. PMID: 25527698.","journal-title":"Circulation"},{"issue":"5","key":"2417_CR14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3390\/biomedicines13051093","volume":"13","author":"N Nita","year":"2025","unstructured":"Nita N, Felbel D, Melnic R, Paukovitsch M, Rottbauer W, Buckert D, M\u00f6rike J. Predictors of Poor Long-Term Outcomes in Patients with Newly Diagnosed Asymptomatic Cardiac Sarcoidosis: A Cardiovascular Magnetic Resonance Study. Biomedicines. 2025;13(5):1093. https:\/\/doi.org\/10.3390\/biomedicines13051093. PMID: 40426920; PMCID: PMC12109307.","journal-title":"Biomedicines"},{"issue":"5","key":"2417_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jacasi.2023.07.006","volume":"3","author":"H Kamada","year":"2023","unstructured":"Kamada H, Ishibashi K, Miyazaki Y, Wakamiya A, Ueda N, Nakajima K, Kamakura T, Wada M, Takaya Y, Inoue Y, Miyamoto K, Nagase S, Aiba T, Yazaki Y, Isobe M, Terasaki F, Ohishi M, Kusano KF. Fatal Arrhythmic Risks in Cardiac Sarcoidosis With Mildly Impaired Cardiac Function. JACC Asia. 2023;3(5):755\u201363. PMID: 38094999; PMCID: PMC10715887.","journal-title":"JACC Asia"},{"issue":"10","key":"2417_CR16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jamacardio.2022.2981","volume":"7","author":"PSS Athwal","year":"2022","unstructured":"Athwal PSS, Chhikara S, Ismail MF, Ismail K, Ogugua FM, Kazmirczak F, Bawaskar PH, Elton AC, Markowitz J, von Wald L, Roukoz H, Bhargava M, Perlman D, Shenoy C. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis. JAMA Cardiol. 2022;7(10):1057\u201366. https:\/\/doi.org\/10.1001\/jamacardio.2022.2981. PMID: 36103165; PMCID: PMC9475438.","journal-title":"JAMA Cardiol"},{"issue":"6","key":"2417_CR17","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1378\/chest.07-2784","volume":"133","author":"D Mehta","year":"2008","unstructured":"Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, Machac J, Teirstein A. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008;133(6):1426\u201335. https:\/\/doi.org\/10.1378\/chest.07-2784. Epub 2008 Mar 13. PMID: 18339784.","journal-title":"Chest"},{"key":"2417_CR18","doi-asserted-by":"publisher","unstructured":"Sohn DW, Park JB. Cardiac sarcoidosis. Heart. 2023;109(15):1132\u20131138. https:\/\/doi.org\/10.1136\/heartjnl-2022-321379. PMID: 36631144.","DOI":"10.1136\/heartjnl-2022-321379"},{"key":"2417_CR19","doi-asserted-by":"publisher","unstructured":"Ekstr\u00f6m K, Lehtonen J, Nordenswan HK, M\u00e4yr\u00e4np\u00e4\u00e4 MI, R\u00e4is\u00e4nen-Sokolowski A, Kandolin R, Simonen P, Pietil\u00e4-Effati P, Alatalo A, Utriainen S, Rissanen TT, Haataja P, Kokkonen J, Vihinen T, Miettinen H, Kaikkonen K, Kerola T, Kupari M. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J. 2019;40(37):3121\u20133128. https:\/\/doi.org\/10.1093\/eurheartj\/ehz428. PMID: 31230070.","DOI":"10.1093\/eurheartj\/ehz428"},{"issue":"24","key":"2417_CR20","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.3390\/jcm13247657","volume":"13","author":"A Druyan","year":"2024","unstructured":"Druyan A, Shuv N, Lidar M. Put Down the ACE: Low Clinical Utility for Angiotensin-Converting Enzyme Levels in Sarcoidosis: A Single-Center Retrospective Cohort Study. J Clin Med. 2024;13(24):7657. https:\/\/doi.org\/10.3390\/jcm13247657. PMID: 39768579; PMCID: PMC11677637.","journal-title":"J Clin Med"},{"key":"2417_CR21","doi-asserted-by":"publisher","unstructured":"Stevenson A, Bray JJH, Tregidgo L, Ahmad M, Sharma A, Ng A, Siddiqui A, Khalid AA, Hylton K, Ionescu A, Providencia R, Kirresh A. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2023;16(3):345\u2013357. https:\/\/doi.org\/10.1016\/j.jcmg.2022.10.018.\u00a0Epub 2023 Jan 11. PMID: 36752432.","DOI":"10.1016\/j.jcmg.2022.10.018"},{"key":"2417_CR22","doi-asserted-by":"publisher","unstructured":"Donnelly R, Franciosi AN, Forde SH, McDermott M, Keane MP, Murphy DJ, McGrath EE, McCarthy C. Deciphering the Role of FDG-PET\/CT Imaging in the Management of Sarcoidosis. Chest. 2025;S0012-3692(25)00226-0. https:\/\/doi.org\/10.1016\/j.chest.2025.02.017. Epub ahead of print. PMID: 40015600.","DOI":"10.1016\/j.chest.2025.02.017"},{"issue":"3","key":"2417_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/ejhf.3545","volume":"27","author":"H M\u00e4lk\u00f6nen","year":"2025","unstructured":"M\u00e4lk\u00f6nen H, Lehtonen J, P\u00f6yh\u00f6nen P, Uusitalo V, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Kupari M. Endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Eur J Heart Fail. 2025;27(3):488\u201397. https:\/\/doi.org\/10.1002\/ejhf.3545. Epub 2024 Dec 5. PMID: 39639404; PMCID: PMC11955311.","journal-title":"Eur J Heart Fail"},{"key":"2417_CR24","first-page":"100342","volume":"23","author":"DR Okada","year":"2019","unstructured":"Okada DR, Smith J, Derakhshan A, Gowani Z, Zimmerman SL, Misra S, Berger RD, Calkins H, Tandri H, Chrispin J. Electrophysiology study for risk stratification in patients with cardiac sarcoidosis and abnormal cardiac imaging. Int J Cardiol Heart Vasc. 2019;23:100342. PMID: 31321283; PMCID: PMC6612749.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"1","key":"2417_CR25","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TW. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(1):19\u201327. PMID: 24751450.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"7","key":"2417_CR26","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, Soejima K. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305\u201323. Epub 2014 May 9. PMID: 24819193.","journal-title":"Heart Rhythm"},{"issue":"11","key":"2417_CR27","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, Inomata T, Ishibashi-Ueda H, Eishi Y, Kitakaze M, Kusano K, Sakata Y, Shijubo N, Tsuchida A, Tsutsui H, Nakajima T, Nakatani S, Horii T, Yazaki Y, Yamaguchi E, Yamaguchi T, Ide T, Okamura H, Kato Y, Goya M, Sakakibara M, Soejima K, Nagai T, Nakamura H, Noda T, Hasegawa T, Morita H, Ohe T, Kihara Y, Saito Y, Sugiyama Y, Morimoto SI, Yamashina A, Japanese Circulation Society Joint Working Group. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version. Circ J. 2019;83(11):2329\u201388. https:\/\/doi.org\/10.1253\/circj.CJ-19-0508. Epub 2019 Oct 9. PMID: 31597819.","journal-title":"Circ J"},{"issue":"9923","key":"2417_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(13)60680-7. Epub 2013 Oct 1. PMID: 24090799.","journal-title":"Lancet"},{"issue":"4","key":"2417_CR29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.chest.2024.10.040","volume":"167","author":"R Sangani","year":"2025","unstructured":"Sangani R, Bosch NA, Govender P, Scarpato B, Walkey AJ, Newman J, Law AC, Gillmeyer KR, Shankar DA. Sarcoidosis Treatment Patterns in the United States: 2016\u20132022. Chest. 2025;167(4):1099\u2013106. https:\/\/doi.org\/10.1016\/j.chest.2024.10.040. Epub 2024 Nov 9. PMID: 39522595.","journal-title":"Chest"},{"key":"2417_CR30","doi-asserted-by":"publisher","unstructured":"Ballul T, Borie R, Crestani B, Daugas E, Descamps V, Dieude P, Dossier A, Extramiana F, van Gysel D, Papo T, Sacre K. Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs. Int J Cardiol. 2019;276:208\u2013211. https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.131. PMID: 30527995.","DOI":"10.1016\/j.ijcard.2018.11.131"},{"key":"2417_CR31","doi-asserted-by":"publisher","unstructured":"Griffin JM, Chasler J, Wand AL, Okada DR, Smith JN, Saad E, Tandri H, Chrispin J, Sharp M, Kasper EK, Chen ES, Gilotra NA. Management of Cardiac Sarcoidosis Using Mycophenolate Mofetil as a Steroid-Sparing Agent. J Card Fail. 2021;27(12):1348\u20131358. https:\/\/doi.org\/10.1016\/j.cardfail.2021.06.010. PMID: 34166800.","DOI":"10.1016\/j.cardfail.2021.06.010"},{"issue":"6","key":"2417_CR32","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1093\/rheumatology\/keae692","volume":"64","author":"L Brooks","year":"2025","unstructured":"Brooks L, Kivlin W, Mohananey D, Sabchyshyn V, Putman M. Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis. Rheumatology (Oxford). 2025;64(6):3303\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keae692. PMID: 39724230; PMCID: PMC12107074.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2417_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cardfail.2020.08.013","volume":"27","author":"NA Gilotra","year":"2021","unstructured":"Gilotra NA, Wand AL, Pillarisetty A, Devraj M, Pavlovic N, Ahmed S, Saad E, Solnes L, Garcia C, Okada DR, Constantinescu F, Mohammed SF, Griffin JM, Kasper EK, Chen ES, Sheikh FH. Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience. J Card Fail. 2021;27(1):83\u201391. PMID: 32889044; PMCID: PMC8350936.","journal-title":"J Card Fail"},{"key":"2417_CR34","doi-asserted-by":"publisher","unstructured":"Elwazir M, Krause ML, Bois JP, Christopoulos G, Kendi AT, Cooper LT Jr, Jouni H, Abouezzeddine OF, Chareonthaitawee P, Abdelshafee M, Amin S. (2022). Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience. J Card Fail. 28(2):247\u2013258. https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.008. PMID: 34320381.","DOI":"10.1016\/j.cardfail.2021.07.008"},{"key":"2417_CR35","doi-asserted-by":"publisher","unstructured":"Kron J, Mauro AG, Bonaventura A, Toldo S, Salloum FN, Ellenbogen KA, Abbate A. Inflammasome Formation in Granulomas in Cardiac Sarcoidosis. Circ Arrhythm Electrophysiol. 2019;12(9):e007582. https:\/\/doi.org\/10.1161\/CIRCEP.119.007582. PMID: 31522533.","DOI":"10.1161\/CIRCEP.119.007582"},{"issue":"5","key":"2417_CR36","doi-asserted-by":"publisher","first-page":"e011869","DOI":"10.1161\/CIRCEP.123.011869","volume":"16","author":"J Kron","year":"2023","unstructured":"Kron J, Crawford T, Bogun F, Jordan JH, Koelling T, Syed H, Syed A, Iden T, Polly K, Federmann EG, Bray K, Lathkar-Pradhan S, Ladd A, Dickson VM, Barron A, Tavoosi A, Beanlands R, Birnie D, Ellenbogen K, Van Tassell BW, Hundley WG, Abbate A. Interleukin-1 Blockade in Cardiac Sarcoidosis: A Pilot Study. Circ Arrhythm Electrophysiol. 2023;16(5):e011869. https:\/\/doi.org\/10.1161\/CIRCEP.123.011869. PMID: 37092332; PMCID: PMC10192113.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2417_CR37","doi-asserted-by":"publisher","unstructured":"Rosenbaum AN, Wagle A, Meuth CL, Wang S, Paolini JF, Bratcher MA, Chareonthaitawee P, Gilotra NA. Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS). J Card Fail. 2026;32(5):877\u2013887. https:\/\/doi.org\/10.1016\/j.cardfail.2026.03.010. PMID: 42128581.","DOI":"10.1016\/j.cardfail.2026.03.010"},{"issue":"36","key":"2417_CR38","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"issue":"37","key":"2417_CR39","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195.","journal-title":"Eur Heart J"},{"issue":"11","key":"2417_CR40","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.3390\/jcm13113165","volume":"13","author":"S Arunachalam Karikalan","year":"2024","unstructured":"Arunachalam Karikalan S, Yusuf A, El Masry H. Arrhythmias in Cardiac Sarcoidosis: Management and Prognostic Implications. J Clin Med. 2024;13(11):3165. https:\/\/doi.org\/10.3390\/jcm13113165. PMID: 38892878; PMCID: PMC11172558.","journal-title":"J Clin Med"},{"key":"2417_CR41","doi-asserted-by":"publisher","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M, ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262. PMID: 36017572.","DOI":"10.1093\/eurheartj\/ehac262"},{"issue":"1","key":"2417_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","volume":"8","author":"S Kumar","year":"2015","unstructured":"Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, Maytin M, Albert CM, Miller AL, Koplan BA, Michaud GF, Tedrow UB, Stevenson WG. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8(1):87\u201393. Epub 2014 Dec 19. PMID: 25527825.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"17","key":"2417_CR43","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","volume":"44","author":"J Lehtonen","year":"2023","unstructured":"Lehtonen J, Uusitalo V, P\u00f6yh\u00f6nen P, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J. 2023;44(17):1495\u2013510. https:\/\/doi.org\/10.1093\/eurheartj\/ehad067. PMID: 36924191; PMCID: PMC10149532.","journal-title":"Eur Heart J"},{"key":"2417_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.amjcard.2023.07.088","volume":"204","author":"K Arps","year":"2023","unstructured":"Arps K, Doss J, Geiger K, Flores-Rosario K, DeVore AD, Karra R, Kim HW, Piccini JP, Pokorney SD, Sun AY. Incidence and Predictors of Relapse After Weaning Immune Suppressive Therapy in Cardiac Sarcoidosis. Am J Cardiol. 2023;204:249\u201356. Epub 2023 Aug 8. PMID: 37556894.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2417_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.healun.2021.08.012","volume":"41","author":"KC Jackson","year":"2022","unstructured":"Jackson KC, Youmans QR, Wu T, Harap R, Anderson AS, Chicos A, Ezema A, Mandieka E, Ohiomoba R, Pawale A, Pham DT, Russell S, Sporn PHS, Yancy CW, Okwuosa IS. Heart transplantation outcomes in cardiac sarcoidosis. J Heart Lung Transpl. 2022;41(1):113\u201322. Epub 2021 Aug 30. PMID: 34756511.","journal-title":"J Heart Lung Transpl"},{"issue":"2","key":"2417_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00392-021-01920-0","volume":"111","author":"E Bobbio","year":"2022","unstructured":"Bobbio E, Bj\u00f6rkenstam M, Nwaru BI, Giallauria F, Hessman E, Bergh N, Polte CL, Lehtonen J, Karason K, Bollano E. Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis. Clin Res Cardiol. 2022;111(2):125\u201340. https:\/\/doi.org\/10.1007\/s00392-021-01920-0. Epub 2021 Aug 17. PMID: 34402927; PMCID: PMC8816313.","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"2417_CR47","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s11886-013-0370-6","volume":"15","author":"H Skali","year":"2013","unstructured":"Skali H, Schulman AR, Dorbala S. 18F-FDG PET\/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013;15(4):352. PMID: 23544184; PMCID: PMC4009625.","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"2417_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41824-019-0056-4","volume":"3","author":"K Fukushima","year":"2019","unstructured":"Fukushima K, Nagao M, Yamamoto A, Serizawa N, Ishizaki U, Suzuki A, Sakai A, Watanabe E, Momose M, Kuji I, Abe K. Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and 18F fluorodeoxyglucose positron emission tomography. Eur J Hybrid Imaging. 2019;3(1):9. https:\/\/doi.org\/10.1186\/s41824-019-0056-4. PMID: 34191189; PMCID: PMC8218105.","journal-title":"Eur J Hybrid Imaging"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02417-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:03:03Z","timestamp":1790794983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02417-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2417"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02417-w","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial intelligence (AI) tools were used to assist with language editing, preparation of revisions, and organization of references and tabular content. No original data were analyzed by AI. All scientific statements, citations, and tables were independently verified, critically revised, and approved by the authors, who take full responsibility for the final manuscript.","order":2,"name":"Ethics","label":"Use of Artificial Intelligence","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"101"}}